The global politics of intellectual property rights and pharmaceutical drug policies in developing countries

International Political Science Review

Volumn 24, Issue 2, 2003, Pages 181-197+273

  Lanoszka, Anna ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

Author keywords

Access to affordable medicines; Developing countries; TRIPS Agreement; WTO

Indexed keywords

EID: 0038245115     PISSN: 01925121     EISSN: None     Source Type: Journal    
DOI: 10.1177/0192512103024002002     Document Type: Article

References (39)

1. Abbott, Frederick M. (2002). "The TRIPS Agreement, Access to Medicines, and the WTO Doha Ministerial Conference." Journal of World Intellectual Property, 5: 15-52.
2. Azmi, Ida Madieha and Rokiah Alavi (2001). "TRIPS, Patents, Technology Transfer, Foreign Direct Investment and the Pharmaceutical Industry in Malaysia." Journal of World Intellectual Property, 4: 947-976.
3. Braga, Carlos A. Primo (1996). "Trade-related Intellectual Property Issues: the Uruguay Round Agreement and its Economic Implications." In The Uruguay Round and the Developing Countries (Will Martin and Alan Winters, eds). Cambridge: Cambridge University Press.
4. Correa, Carlos M. (2000). Intellectual Property Rights, the WTO and Developing Countries - The TRIPS Agreement and Policy Options. Penang, Malaysia: Third World Network.
5. Croome, John (1995). Reshaping the World Trading System - A History of the Uruguay Round, Geneva: WTO.
6. Financial Times (2001a). "US in Talks on Anthrax Patent." 21 October.
7. Financial Times (2001b). "Editorial Comment: Patent Abuse." 22 October.
8. GATT (1990a). Draft Agreement on Trade-Related Aspects of Intellectual Property Rights, (MTN.GNG/NG11/W/68), Article 24 (2), 29 March.
9. GATT (1990b). Communication from Argentina, Brazil, Chile, China, Colombia, Cuba, Egypt, India, Nigeria, Peru, Tanzania and Uruguay, Article 6, 14 May.
10. Globe and Mail (2001). "Ottawa Pays Twice for Cipro." 23 October.
11. Grey, Rodney de C. (1982). United States Trade Policy Legislation: A Canadian View. Montreal: Institute for Research on Public Policy.
12. Inside US Trade (2001). "Oxfam Seeks Major Changes in TRIPS Rules to Lower Drug Prices." 16 February.
13. Kondo, Edson K. (1995). "The Effect of Patent Protection on Foreign Direct Investment." Journal of World Trade, 29: 97-122.
14. Kongolo, Tshimanga (2001). "Public Interest Versus the Pharmaceutical Industry's Monopoly in South Africa." Journal of World Intellectual Property, 4: 609-627.
15. MacLeod, Christine (1991). "The Paradoxes of Patenting: Invention and its Diffusion in 18th and 19th Century Britain, France, and North America." Technology and Culture, 32: 885-911.
16. Mansfield, Edwin (1995). Intellectual Property Protection, Foreign Direct Investment, and Technology Transfer: Germany, Japan, and the US. Discussion Paper No. 27. Washington, DC: World Bank.
17. Maskus, Keith E. (2000). Intellectual Property Rights in the Global Economy. Washington, DC: Institute for International Economics.
18. Mukerji, Asoke (2000). "Developing Countries and the WTO - Issues of Implementation." Journal of World Trade, 34: 33-74.
19. Ostry, Sylvia (1990). Governments and Corporations in a Shrinking World - Trade and Innovation Policies in the United States, Europe and Japan. New York: Council on Foreign Relations.
20. Otten, Adrian (1998). "Implementation of the TRIPS Agreement and Prospects for its Further Development." Journal of International Economic Law, 1: 523-536.
21. Raghavan, Chakravarthi (1997). "A New Trade Order in a World of Disorder." In World Trade - Toward Fair and Free Trade in the Twenty-First Century (Jo Marie Griesgraber and Bernhard G. Gunter, eds). London: Pluto Press.
22. Ryan, Michael P. (1998). Knowledge Diplomacy: Global Competition and the Politics of Intellectual Property. Washington, DC: Brookings Institution Press.
23. Stiglitz, Joseph E. (1999). "Two Principles for the Next Round or How to Bring Developing Countries in from the Cold." Paper presented at the conference organized by UNCTAD and the World Bank, Geneva, Switzerland, 21 September.
24. Templeman, Lord Sydney (1998). "Intellectual Property." Journal of International Economic Law, 1: 603-606.
25. UNDP (United Nations Development Program) (1999). Human Development Report 1999 - Globalization with a Human Face. Geneva: UNDP.
26. UNDP (2001). The Human Development Report 2001, 10 July. Geneva: UNDP.
27. WHO (1999). Executive Board Resolution EB103.R1, 26 January. Tabled by the World Health Assembly, 52nd session, 17-25 May 1999, Articles 1.3 and 2.7.
28. WTO (1996a). India - Patent Protection for Pharmaceutical and Agricultural Chemical Products - Complaint by the United States, (WT/DS50). Geneva: WTO.
29. WTO (1996b). India - Patent Protection for Pharmaceutical and Agricultural Chemical Products - Complaint by the US, (WT/DS50/1), 9 July. Geneva: WTO.
30. WTO (1997). "Report of the Appellate Body," (WT/DS50/AB/R), 19 December. Geneva: WTO.
31. WTO (2000a). Implementation-Related Issues and Concerns - Decision by General Council, (WT/L/384), 19 December. Geneva: WTO.
32. WTO (2000b). Argentina - Certain Measures on the Protection of Patents and Test Data, Complaint by the United States, (WT/DS196/1), 6 June. Geneva: WTO.
33. WTO (2000c). Brazil - Measures Affecting Patent Protection, Complaint by the United States, (WT/DS199), 8 June. Geneva: WTO.
34. WTO (2000d). Brazil - Measures Affecting Patent Protection - Complaint by the US, (WT/DS199/1), 8 June. Geneva: WTO.
35. WTO (2000e). Request to Join Consultation by the EC, (WT/DS199/2), 20 June. Geneva: WTO.
36. WTO (2001a). Declaration on the TRIPS Agreement and Public Health, (WT/MIN/(01)/DEC/W/2), 14 November. Geneva: WTO.
37. WTO (2001b). Implementation-Related Issues and Concerns, (WT/MIN/(01)/DEC/W/10), 14 November. Geneva: WTO.
38. WTO (2001c). Request for Establishment of the Panel, (WT/DS199/3), 8 January. Geneva: WTO.
39. WTO (2001d). Mutually Agreed Solution, (WT/DS199/4), 19 July. Geneva: WTO.